Tratamiento del rechazo agudo hiperinmune con plasmaféresis y rituximab: Nuestra experiencia Treating acute hyperimmune rejection with plasmapheresis and Rituximab: our experience

Tratamiento del rechazo agudo hiperinmune con plasmaféresis y rituximab: Nuestra experiencia Treating acute hyperimmune rejection with plasmapheresis and Rituximab: our experience

Bibliographic Details
Main Authors:	Raquel Pérez Uceta, Esther Llorente Sansano, Joseba Iñaki Agüero Jurado, Gema Briceño Sánchez, Mª Ángeles Gálvez Velasco, Mª Isabel Bravo Moreno
Format:	Article
Language:	Spanish
Published:	Sociedad Española de Enfermería Nefrológica 2012-06-01
Series:	Enfermería Nefrológica
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S2254-28842012000200010

Similar Items

Successful Treatment of Incomplete Susac Syndrome with Simultaneous Corticosteroids and Plasmapheresis Followed by Rituximab
by: Mick B. Reedy, et al.
Published: (2021-01-01)

Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation
by: Martalena Ramli, et al.
Published: (2019-06-01)

Comparing Plasmapheresis plus IVIg with Plasmapheresis plus IVIg plus Rituximab on the Management of Suspicious Antibody-Mediated Acute Rejection in Kidney Transplant Recipients
by: F Ahmadi, et al.
Published: (2019-07-01)

B cells and immunoglobulin in ABO-incompatible renal transplant patients receiving rituximab and double filtration plasmapheresis
by: Meng-Kun Tsai, et al.
Published: (2015-04-01)

Case Series of 3 Patients Diagnosed With Atypical Hemolytic Uremic Syndrome Successfully Treated With Steroids, Plasmapheresis, and Rituximab
by: Jeffery M. Patterson, et al.
Published: (2017-12-01)

Efecto de la plasmaféresis productiva automatizada en donantes voluntarios Effect of productive automated plasmapheresis on voluntary donors
by: Roberto Fano Viamonte, et al.
Published: (2007-04-01)

Plasmaféresis tiroidea
by: Jorge Rojo Álvaro, et al.
Published: (2020-09-01)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
by: Sonia Boyer-Suavet, et al.
Published: (2020-01-01)

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives
by: Edgardo E. Espinosa Estrada, et al.
Published: (2010-12-01)

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
by: Faisal Musa, et al.
Published: (2015-04-01)

A Case of Subacute Cutaneous Lupus Erythematosus in a Patient with Mixed Connective Tissue Disease: Successful Treatment with Plasmapheresis and Rituximab
by: M. Fantò, et al.
Published: (2013-01-01)

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial
by: Zinzani Pier, et al.
Published: (2012-10-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-05-01)

Rituximab in dermatology: Revisited
by: Aditya Kumar Bubna
Published: (2020-01-01)

Commentary: Rituximab in scleritis
by: Parthopratim Dutta Majumder
Published: (2020-01-01)

RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
by: E.I. Alexeeva, et al.
Published: (2010-01-01)

Rituximab in Membranous Nephropathy
by: Philipp Gauckler, et al.
Published: (2021-04-01)

Rituximabe na síndrome de Felty refratária Rituximab in the refractory Felty's syndrome
by: Thiago Sotero Fragoso, et al.
Published: (2009-04-01)

Economic Evaluation of Rituximab + Recombinant Human Thrombopoietin vs. Rituximab for the Treatment of Second-Line Idiopathic Thrombocytopenic Purpura in China
by: Mingjun Rui, et al.
Published: (2021-03-01)

Cardiac side effect of rituximab
by: Vaibhav Bansidhar Patil, et al.
Published: (2020-01-01)

Rituximab in Minimal Change Disease
by: Nima Madanchi, et al.
Published: (2017-03-01)

Rituximab for Autoimmune Encephalitis with Epilepsy
by: Mohankumar Kurukumbi, et al.
Published: (2020-01-01)

Rituximab in Autoimmune CNS Disease
by: J Gordon Millichap, et al.
Published: (2014-08-01)

Rituximab in the treatment of skin diseases
by: Murlidhar Rajagopalan, et al.
Published: (2017-01-01)

Safety of rituximab in rheumatoid arthritis
by: F. Atzeni, et al.
Published: (2011-06-01)

Rituximab and Cytokine Release Syndrome
by: Hrishikesh S. Kulkarni, et al.
Published: (2012-03-01)

Lupus nephritis, pregnancy and rituximab
by: Enrique Dorado, et al.
Published: (2017-04-01)

Rituximab-Induced Coronary Vasospasm
by: Linda Lee, et al.
Published: (2012-01-01)

Rituximab in treatment of idiopathic glomerulopathy
by: Kamel El-Reshaid, et al.
Published: (2012-01-01)

Rituximab for the treatment of rheumatoid arthritis
by: A Bagust, et al.
Published: (2009-09-01)

Rituximab in kidney disease and transplant
by: Kajal Chauhan, et al.
Published: (2019-06-01)

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
by: Hee Kyung Kim, et al.
Published: (2020-01-01)

Le Tecniche Di Plasmaferesi
by: Ghil Busnach
Published: (1989-04-01)

ANCA-Associated Necrotizing Glomerulonephritis Overlapping with Mesangial Proliferative Lupus Nephritis Refractory to Plasmapheresis, Steroid Pulse Therapy, and a Combination of Mycophenolate Mofetil and Rituximab
by: Saika Sharmeen, et al.
Published: (2018-01-01)

Rituximab no tratamento da síndrome nefrótica
by: Joel Ferreira da Silva
Published: (2019)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Livedoid vasculopathy: experience in using rituximab
by: Yuri Vladimirovich Muravyev, et al.
Published: (2011-08-01)

Multiple sclerosis, rituximab, and COVID‐19
by: Annette Langer‐Gould, et al.
Published: (2021-04-01)

Utilization of Rituximab for Refractory Rowell Syndrome
by: Sukhraj Singh, et al.
Published: (2021-01-01)

EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)